| BNC883347-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3347), CF488A conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
| BNUM2836-50 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2836), 1mg/mL | 1x 50 µL | Sign In for Pricing | |
| BNC683348-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3348), CF568 conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
| BNC043347-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3347), CF405S conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
| BNC942576-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2576), CF594 conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
| BNUB3348-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3348), 0.2mg/mL | 1x 100 µL | Sign In for Pricing | |
| BNC743348-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3348), CF740 conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
| BNCB3348-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3348), Biotin conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
| BNCB2576-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2576), Biotin conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
| BNC742576-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2576), CF740 conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
| BNC472836-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2836), CF647 conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
| BNC882836-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2836), CF488A conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
| BNUB3347-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3347), 0.2mg/mL | 1x 100 µL | Sign In for Pricing | |
| BNUB2576-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2576), 0.2mg/mL | 1x 100 µL | Sign In for Pricing | |
| BNC472576-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2576), CF647 conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
| BNC682576-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2576), CF568 conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
| BNC473350-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3350), CF647 conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
| BNC042836-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2836), CF405S conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
| BNUB3350-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3350), 0.2mg/mL | 1x 500 µL | Sign In for Pricing | |
| BNC473347-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3347), CF647 conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
| BNC403350-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3350), CF640R conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
| BNCB2836-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2836), Biotin conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
| BNCB3350-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3350), Biotin conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
| BNC683348-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3348), CF568 conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
| BNCB2836-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2836), Biotin conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
| BNC882576-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2576), CF488A conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
| BNCB3348-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3348), Biotin conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
| BNC043350-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3350), CF405S conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
| BNC943348-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3348), CF594 conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
| BNC472576-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2576), CF647 conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
| BNC742836-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2836), CF740 conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
| BNUB3348-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3348), 0.2mg/mL | 1x 500 µL | Sign In for Pricing | |
| BNC403348-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3348), CF640R conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
| BNC682576-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2576), CF568 conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
| BNC403350-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3350), CF640R conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
| BNC943350-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3350), CF594 conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
| BNC472836-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2836), CF647 conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
| BNC943350-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3350), CF594 conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
| BNC743350-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3350), CF740 conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
| LY803 | Lymphatic metastatic adenocarcinoma tissue array, 80 cases/80 cores-LY803 | each | Sign In for Pricing | |
| VA1001a | Appendix spectrum of diseases with appendix tissue array, including carcinoid, adenocarcinoma, metastatic carcinoid, tubular adenoma, acute appendicitis, chronic appendicitis, pathology grade, TNM and clinical stage (AJCC 8.0), 50 cases/100 cores (1.5mm) | 1 Each | Sign In for Pricing | |
| MBS4381119-01 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) | 0.02 mg (With BSA & Azide at 0.2mg/mL) | Sign In for Pricing | |
| MBS4381119-02 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) | 0.1 mg (With BSA & Azide at 0.2mg/mL) | Sign In for Pricing | |
| MBS4381119-03 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) | 0.1 mg (Without BSA & Azide at 1mg/mL) | Sign In for Pricing | |
| MBS4381119-04 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) | 5x 0.1 mg (With BSA & Azide at 0.2mg/mL) | Sign In for Pricing | |
| MBS4381119-05 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) | 5x 0.1 mg (Without BSA & Azide at 1mg/mL) | Sign In for Pricing | |
| 36-2857-20 | Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) Monoclonal Antibody (Clone: NKX3.1/2576) | 20 µg | Sign In for Pricing | |
| 36-2857-100 | Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) Monoclonal Antibody (Clone: NKX3.1/2576) | 100 µg | Sign In for Pricing | |
| 36-2858-20 | Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) Monoclonal Antibody (Clone: NKX3.1/3350) | 20 µg | Sign In for Pricing | |
| 36-2858-100 | Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) Monoclonal Antibody (Clone: NKX3.1/3350) | 100 µg | Sign In for Pricing | |